Search Science Hub

Science Hub is Novo Nordisk’s one-stop portal for all our scientific publications and clinical trials, congress materials and medical updates. Sign up to gain full access.

Welcome to Novo Nordisk Science Hub

Are you a healthcare professional?

Cardiometabolic Health Congress (CMHC 2026) 15 - 17 October 2026

Real-World Glycemic Control With High-Dose Once-Weekly Semaglutide 2 mg in Adults With Type 2 Diabetes

Authors :

Nathan Laney¹; Caichen Zhong¹; Yiqiao Zhang¹; Josh Noone¹; Caroline McKay¹; Liana K Billings^2,3

Affiliations

View Details Hide Details

Download poster (.pdf)

Keywords

Diabetes

Congress poster

GLP-1 RA